FICCI Advantage Healthcare India 2026 honours Fortis Bannerghatta as top kidney transplant centre
A key milestone in this journey has been the introduction of TREAT Program, a first-of-its-kind clinical initiative introduced in India
A key milestone in this journey has been the introduction of TREAT Program, a first-of-its-kind clinical initiative introduced in India
The SCOUT-HCM trial hit its primary endpoint, showing a clinically meaningful and statistically significant reduction in Valsalva left ventricular outflow tract
Doctors at the hospital highlighted that robotic-assisted surgery enhances precision through superior 3D visualisation and improved instrument flexibility
The company’s ACC lineup underscores a growing body of evidence backing the drug’s performance beyond controlled trials
The Phase 2 envisionGI study is testing deudomperidone, an experimental drug aimed at treating idiopathic gastroparesis
A next-generation, cell-based immunotherapy, CAR-T therapy engineers a patient’s own immune cells to detect and destroy cancer
Ind-Ra expects chronic therapies to outpace IPM as compliance improves and lifestyle diseases rise
Occlutech develops, manufactures, and commercialises medical devices for congenital heart disease, stroke prevention, and heart failure
The milestone means more than 1,000 men are now enrolled across both Phase 3 programs
Subscribe To Our Newsletter & Stay Updated